[Effect of Prolixan 300 (Azapropazone) on the course of rheumatoid disease and degenerative joint disease. Comparison with indomethacin by means of a double blind test]

Reumatologia. 1979;17(3):365-74.
[Article in Polish]
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Apazone / adverse effects
  • Apazone / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Clinical Trials as Topic
  • Double-Blind Method
  • Female
  • Humans
  • Indomethacin / adverse effects
  • Indomethacin / therapeutic use*
  • Joint Diseases / drug therapy*
  • Male
  • Middle Aged
  • Triazines / therapeutic use*

Substances

  • Triazines
  • Apazone
  • Indomethacin